M Fukumoto Selected Research

M Fukumoto Research Topics

Disease

11	Neoplasms (Cancer) 06/2011 - 03/2000
8	Carcinoma (Carcinomatosis) 01/2009 - 09/2000
5	Ovarian Epithelial Carcinoma 12/2000 - 04/2000
4	Breast Neoplasms (Breast Cancer) 09/2001 - 11/2000
2	Ovarian Neoplasms (Ovarian Cancer) 12/2008 - 09/2001
2	Carcinogenesis 01/2001 - 09/2000
2	Atherosclerosis 03/2000 - 01/2000
1	Pneumonia (Pneumonitis) 03/2015
1	Inflammation (Inflammations) 03/2015
1	Ataxia Telangiectasia (Louis Bar Syndrome) 08/2010
1	Chromosomal Instability (Chromosome Stability) 01/2009
1	Thymus Hyperplasia 05/2007
1	Cerebral Infarction 04/2002
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 05/2001
1	Hypercapnia 03/2001
1	Neoplasm Metastasis (Metastasis) 03/2001
1	Liver Neoplasms (Liver Cancer) 01/2001
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2001
1	Leukemia 01/2001
1	Lung Neoplasms (Lung Cancer) 01/2001
1	Glioma (Gliomas) 11/2000
1	Fibrosis (Cirrhosis) 11/2000
1	Alcoholic Fatty Liver 11/2000
1	Fatty Liver 11/2000
1	Mucinous Cystadenocarcinoma 09/2000
1	Serous Cystadenocarcinoma 09/2000
1	Endometrioid Carcinoma 09/2000
1	Brenner Tumor 09/2000
1	Colonic Neoplasms (Colon Cancer) 08/2000
1	Esophageal Squamous Cell Carcinoma 05/2000
1	Pathologic Neovascularization 04/2000
1	Hypoxia (Hypoxemia) 01/2000

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 04/2001 - 05/2000
4	Thymidine PhosphorylaseIBA 12/2000 - 04/2000
3	Biological ProductsIBA 01/2009 - 04/2000
3	Messenger RNA (mRNA)IBA 11/2001 - 08/2000
3	AntibodiesIBA 09/2000 - 03/2000
2	Cisplatin (Platino)FDA LinkGeneric 11/2001 - 05/2000
2	multidrug resistance-associated protein 1IBA 04/2001 - 04/2001
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2001 - 04/2001
2	Indicators and Reagents (Reagents)IBA 03/2001 - 04/2000
2	EnzymesIBA 12/2000 - 08/2000
2	von Willebrand FactorIBA 09/2000 - 04/2000
2	oxidized low density lipoproteinIBA 03/2000 - 01/2000
1	Interleukin-6 (Interleukin 6)IBA 03/2015
1	Cyclin D1IBA 08/2010
1	Glycogen Synthase Kinase 3 betaIBA 08/2010
1	DNA (Deoxyribonucleic Acid)IBA 08/2010
1	Biomarkers (Surrogate Marker)IBA 01/2009
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2008
1	Protein Kinases (Protein Kinase)IBA 12/2008
1	taxaneIBA 12/2008
1	PlatinumIBA 12/2008
1	2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA 12/2008
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 05/2007
1	CopperIBA 11/2001
1	P-type ATPasesIBA 11/2001
1	AutoantibodiesIBA 05/2001
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2001
1	deoxyhemoglobinIBA 03/2001
1	Hemoglobins (Hemoglobin)IBA 03/2001
1	Cell Adhesion MoleculesIBA 03/2001
1	Cadherins (E-Cadherin)IBA 03/2001
1	beta CateninIBA 03/2001
1	RadonIBA 01/2001
1	Thorium Dioxide (Thorotrast)IBA 01/2001
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 12/2000
1	Estrogen ReceptorsIBA 11/2000
1	Tamoxifen FDA LinkGeneric 11/2000
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2000
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2000
1	AdrenomedullinIBA 10/2000
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2000
1	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2000
1	A-Form DNA (A-DNA)IBA 08/2000
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 08/2000
1	Thymidylate SynthaseIBA 08/2000
1	VimentinIBA 03/2000
1	Keratins (Keratin)IBA 03/2000
1	S100 Proteins (S 100 Protein)IBA 03/2000
1	HeliumIBA 01/2000

Therapy/Procedure

3	Therapeutics 01/2009 - 11/2000
2	Radiotherapy 06/2011 - 08/2010
2	Drug Therapy (Chemotherapy) 12/2008 - 04/2001
1	Oral Hygiene (Dental Hygiene) 03/2015
1	Dentures 03/2015